How do we enhance protective immunity to COVID-19 in lung transplant recipients?

Eur Respir J. 2023 Jan 19;61(1):2201723. doi: 10.1183/13993003.01723-2022. Print 2023 Jan.

Authors

David W J Griffin¹, James H McMahon^{2

3}

Affiliations

¹ Department of Infectious Diseases, Alfred Hospital and Monash University, Melbourne, Australia d.griffin@alfred.org.au.
² Department of Infectious Diseases, Alfred Hospital and Monash University, Melbourne, Australia.
³ Department of Infectious Diseases, Monash Health, Clayton, Australia.

PMID: 36657779
DOI: 10.1183/13993003.01723-2022

No abstract available

Publication types

Editorial
Comment

MeSH terms

COVID-19 Vaccines
COVID-19*
Cohort Studies
Humans
Lung
Transplant Recipients

Substances

COVID-19 Vaccines